Susquehanna Fundamental Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-25,747
Closed -$1.08M 629
2023
Q2
$1.08M Hold
25,747
0.04% 324
2023
Q1
$917K Sell
25,747
-40,821
-61% -$1.48M 0.02% 535
2022
Q4
$2.44M Buy
66,568
+39,172
+143% +$1.55M 0.04% 439
2022
Q3
$1.29M Buy
+27,396
New +$1.77M 0.02% 717
2022
Q1
$3.87M Buy
47,776
+11,622
+32% +$983K 0.08% 363
2021
Q4
$3.71M Sell
36,154
-40,261
-53% -$3.87M 0.1% 266
2021
Q3
$6.68M Sell
76,415
-13,767
-15% -$1.25M 0.12% 217
2021
Q2
$8.07M Sell
90,182
-28,050
-24% -$2.37M 0.15% 180
2021
Q1
$8.97M Hold
118,232
0.15% 174
2020
Q4
$8.05M Buy
118,232
+57,019
+93% +$3.55M 0.15% 185
2020
Q3
$3.25M Buy
61,213
+28,613
+88% +$1.7M 0.1% 278
2020
Q2
$1.9M Buy
+32,600
New +$1.75M 0.09% 293

Other funds holding SYNH

Susquehanna Fundamental Investments's SYNH Position: Q3 2023 in Review

Susquehanna Fundamental Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 25,747 shares — an estimated $1.08M sold.

Susquehanna Fundamental Investments first reported a position in SYNH in Q2 2020 and held it in 12 quarters. The position peaked at $8.97M in Q1 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Susquehanna Fundamental Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 25,747 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.08M.
  • Susquehanna Fundamental Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2020 and held it in 12 quarters.
  • Susquehanna Fundamental Investments's Syneos Health, Inc. Class A Common Stock position peaked at $8.97M in Q1 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2023, filed 14 Nov 2023.